Ventricular Function, Left
Research News and Information

Saturday, November 21, 2009

Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta.

30 Oct 2009 BACKGROUND: It remains controversial whether aprotinin use during cardiac surgery is cardioprotective or detrimental. In contrast, volatile anesthetics may offer cardioprotection perioperatively. Increased nitric oxide, protein kinase C activation, ... Read more...

Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure.

25 Oct 2009 OBJECTIVES: The purpose of this study was to determine whether different profiles of cardiac troponin T (cTnT) values assessed over time would yield incremental prognostic information on clinically stable outpatients with heart failure (HF). ... Read more...

Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).

13 Oct 2009 The early mitral flow deceleration time (DTE) is a prognostically validated marker of left ventricular diastolic dysfunction. It has been reported that the DTE is influenced by the loading conditions, which can vary during antihypertensive ... Read more...

Latest indexed articles for 'Ventricular Function, Left'

These are the very latest articles for this heading:

• Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta. 30 Oct 2009
• Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. 25 Oct 2009
• Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy). 13 Oct 2009
• Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling. 13 Oct 2009
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. 11 Oct 2009
• Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony. 10 Oct 2009
• Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial. 29 Sep 2009
• Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. 29 Sep 2009
• Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? 29 Sep 2009
• Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. 29 Sep 2009
• Long-term effects of perindopril on left ventricular structure and function in patients with stable coronary artery disease: a conventional and Doppler tissue echocardiographic pilot study. 29 Sep 2009
• Local wound p38 MAPK inhibition attenuates burn-induced cardiac dysfunction. 29 Sep 2009
• Left ventricular mass regression after porcine versus bovine aortic valve replacement: a randomized comparison. 29 Sep 2009
• Early and midterm outcomes for tricuspid valve surgery after left-sided valve surgery. 29 Sep 2009
• Nonresectional repair of the barlow mitral valve: importance of dynamic annular evaluation. 29 Sep 2009
• Association of the parameters derived from the relation between RR intervals and left ventricle performance with a history of heart failure in patients with atrial fibrillation. 29 Sep 2009
• Interaction of left ventricular geometry and myocardial ischemia in the response of myocardial deformation to stress. 29 Sep 2009
• Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest. 29 Sep 2009
• Positive end-expiratory pressure improves survival in a rodent model of cardiopulmonary resuscitation using high-dose epinephrine. 29 Sep 2009
• Placing a saline bag underneath the displaced heart enhances transgastric transesophageal echocardiographic imaging during off-pump coronary artery bypass surgery. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Ventricular Function, Left'

Definition: The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.

Descriptor UI: D016277

Alternative terms: Ventricular Function, Left; Left Ventricular Function; Function, Left Ventricular; Functions, Left Ventricular; Left Ventricular Functions; Ventricular Functions, Left;

Allowable Qualifiers: drug effects; genetics; immunology; physiology; radiation effects; ethics;

Tree Number: G09.330.190.962.800;

History Note: 91